Enzolytics Inc. Share Price Other OTC
Equities
ENZC
US2941121079
Biotechnology & Medical Research
Sales 2009 | 0.01 1.23 | Sales 2010 | 0.04 3.08 | Capitalization | 7.45M 621M |
---|---|---|---|---|---|
Net income 2009 | - 0 | Net income 2010 | -7M -584M | EV / Sales 2009 | 32,53,15,067 x |
Net Debt 2009 | 924K 77.02M | Net Debt 2010 | 328K 27.32M | EV / Sales 2010 | 21,04,45,953 x |
P/E ratio 2009 * |
-
| P/E ratio 2010 |
-0.29
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 16/17/16 |
Joseph Cotropia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gaurav Chandra
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 16/17/16 |
Joseph Cotropia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gaurav Chandra
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |